|
|
 |
|
Viewing report
|
|
 |
 |
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
ADIS, Jan 2001, Pages: 247
The objective of this special client report is to identify 25+ innovative drugs in autoimmune and inflammatory disease therapeutics which are available for partnering, licensing and/or co-marketing.
The entire realm of autoimmune and inflammatory disease therapeutics is considered, segmented, evaluated and forecast as a backdrop for this opportunity analysis.
This special report provides an in-depth assessment of those programs which represent potential breakthrough therapies.
Customers who bought this item also bought
Antiviral Drug Licensing Opportunities: Analysis, Rating, and Ranking - A Worldwide Study
Drugs of Tomorrow 2001: Diabetes
25+ Business Development and Innovation Opportunities in Diabetes and Related Conditions - Emerging Opportunities to 2010
CNS Drug Licensing: Opportunities, Analysis, Rating and Ranking - A Worldwide Study
Drugs of Tomorrow 2001: Stable Angina - An Unsatisfactory R&D Pipeline Facing Chronic Unmet Needs
25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs
Drug Delivery 2000: A Key Company and Market Analysis
Cardiology Drug Licensing Opportunities, 2002
Cardiovascular Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
Market Dynamics 2001: Hormonals
Atherosclerosis: Strategic Audit of Marketplace Activity Issues and Implications
|
 |
|
|